Cannabinoids

758 Subject Index

AEA seeanandamide
AEA-hydrolase seefatty acid
amide hydrolase
age 390
agnathan 290
agonists seecannabinoid receptor
agonists
AIDS seeacquired immune defi-
ciency syndrome
Akt phosphorylation 610
alkylcarbamic acid aryl esters 193
allosteric 6
allosteric site 35, 36
alternate matrix 682
Alzheimer’s disease 491, 499, 728,
735
AM1172 200, 201
AM1241 8, 20, 221, 234, 236, 531,
532
AM2233 435
AM251 10, 21–23, 31, 434, 613, 616,
617
AM281 10, 21–23, 30, 435
AM374 192
AM404 199, 200
AM630 10, 22–24, 32, 617
amphibians 290
Amphioxus 291
amygdala 337, 339, 433, 456, 467
basolateral complex 310
anandamide (AEA) 5, 6, 8, 14, 16–
18, 26–37, 55, 149, 284, 293,
294, 368, 375, 574, 576, 580,
582, 583, 590, 591, 600–618,
697
biosynthesis,release,uptakeand
metabolism of seeendo-
cannabinoids
ANKTM1 1, 31, 167, 293
annelid 285, 287
antagonists seecannabinoidrecep-
tor antagonists
anterior pituitary 557
adenomas 563
corticotrope cells 559
anti-emetic properties 733

antibody response 394

anxiety disorders 738

apoptosis 565, 630

appetite and feeding 559

appetite stimulation 734

appetite suppression 736

Arabidopsis 287, 293, 294

arachidonic acid 285, 286, 288

arachidonoyldopamine 190

arachidonoylserotonin 193

arachidonoyltrifluoro-

methylketone 191

area postrema 581, 585, 586, 589

arvanil 561

Ashworth scale/score 725, 726

Aspergillus 402, 404

assays 6–12

binding 6–9

functional 9–12

asthma 739

astrocytes 412

ataxia 723

ATFMK 192, 197

auditory attention task 437

autonomic nervous system 345

autoradiography 426

avoidance 459

active 458

inhibitory 457

axon terminals

CB 1 receptor 331

B cell differentiation 394

B lymphocytes 394

basal forebrain 310, 556

basal forebrain cholinergic 311

basal ganglia 311, 354, 499

caudate-putamen 485, 488,

491, 492, 499

entopeduncular nucleus 488,

496

globus pallidus 485, 488–491

substantianigra 485,488–490,

496

subthalamic nucleus 488, 497

basket cell(s) 341, 355